Market Cap 34.19B
Revenue (ttm) 4.69B
Net Income (ttm) 1.02B
EPS (ttm) N/A
PE Ratio 26.33
Forward PE 24.57
Profit Margin 21.79%
Debt to Equity Ratio 0.13
Volume 518,400
Avg Vol 897,344
Day's Range N/A - N/A
Shares Out 146.87M
Stochastic %K 19%
Beta 0.70
Analysts Sell
Price Target $266.45

Latest News on RMD

Jan De Witte joins GHO Capital as Operating Partner

Feb 11, 2025, 4:30 AM EST - 11 days ago

Jan De Witte joins GHO Capital as Operating Partner

IART


Stock Of The Day: Trading The Range In ResMed

Feb 3, 2025, 12:59 PM EST - 19 days ago

Stock Of The Day: Trading The Range In ResMed


ResMed Inc. (RMD) Q2 2025 Earnings Call Transcript

Jan 30, 2025, 9:10 PM EST - 23 days ago

ResMed Inc. (RMD) Q2 2025 Earnings Call Transcript


ResMed CEO On Earnings, Sleep Apnea

Oct 29, 2024, 11:23 AM EDT - 4 months ago

ResMed CEO On Earnings, Sleep Apnea


ResMed Inc. (RMD) Q1 2025 Earnings Call Transcript

Oct 24, 2024, 11:14 PM EDT - 4 months ago

ResMed Inc. (RMD) Q1 2025 Earnings Call Transcript


My Top 15 High Growth Dividend Stocks For October 2024

Oct 3, 2024, 12:04 PM EDT - 5 months ago

My Top 15 High Growth Dividend Stocks For October 2024

ACN APH DPZ ELV GPN INTU MA


Why ResMed's Rally Is Just Getting Started

Sep 18, 2024, 11:30 AM EDT - 5 months ago

Why ResMed's Rally Is Just Getting Started


ResMed Shares Breathing Life into Big Money Portfolios

Aug 9, 2024, 2:07 PM EDT - 7 months ago

ResMed Shares Breathing Life into Big Money Portfolios


ResMed Inc. (RMD) Q4 2024 Earnings Call Transcript

Aug 1, 2024, 10:58 PM EDT - 7 months ago

ResMed Inc. (RMD) Q4 2024 Earnings Call Transcript